Clinical characteristics | Oxford classification (n [%]) | ||
---|---|---|---|
Female (n [%]) | 223 (55.3) | Mesangial hypercellularity | |
Age (years, mean [SD]) | 37.1 (11.8) | M0 | 280 (69.4) |
Systolic blood pressure (mmHg, mean [SD]) | 129.7 (18.1) | M1 | 121 (30.0) |
Diastolic blood pressure (mmHg, mean [SD]) | 81.4 (12.1) | Endocapillary hypercellularity | |
MAP (mmHg, mean [SD]) | 97.6 (13.4) | E0 | 274 (68) |
Hemoglobin (g/L, mean [SD]) | 125.9 (1 9.0) | E1 | 127 (31.5) |
Serum creatinine (μmol/L, mean [SD]) | 87.7 (46.3) | Segmental glomerulosclerosis | |
eGFR (ml/min/1.73 m2, mean [SD]) | 94.5 (30.9) | S0 | 101 (25.1) |
24 h urinary protein (g/L, median [IQR]) | 1.2 (1.5) | S1 | 300 (74.4) |
Serum C3 (g/L, mean [SD]) | 0.95 (0.19) | Tubular atrophy/interstitial fibrosis | |
Serum C4 (g/L, mean [SD]) | 0.22 (0.07) | T0 | 294 (73.0) |
T1 | 84 (20.8) | ||
T2 | 23 (5.7) |